Education
About Us
Working with TipRanks
Follow Us
Endra Life Sciences (NDRA)
:NDRA
Total Valuation
ENDRA Life Sciences has a market cap or net worth of $2.37M. The enterprise value is $20.59B.
Market Cap$2.37M
Enterprise Value$20.59B
Share Statistics
ENDRA Life Sciences has 738,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding738,370
Owned by Insiders19.77%
Owned by Institutions―
Financial Efficiency
ENDRA Life Sciences’s return on equity (ROE) is -4.49 and return on invested capital (ROIC) is -459.95%.
Return on Equity (ROE)-4.49
Return on Assets (ROA)-2.58
Return on Invested Capital (ROIC)-459.95%
Return on Capital Employed (ROCE)-4.72
Revenue Per Employee0.00
Profits Per Employee-548.00K
Employee Count21
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of ENDRA Life Sciences is -0.11. ENDRA Life Sciences’s PEG ratio is 94.81.
PE Ratio-0.11
PS Ratio0.00
PB Ratio2.86K
Price to Fair Value0.49
Price to FCF-1.59K
Price to Operating Cash Flow-1.61K
PEG Ratio94.81
Income Statement
In the last 12 months, ENDRA Life Sciences had revenue of 0.00 and earned -11.51M in profits. Earnings per share was -56.94.
Revenue0.00
Gross Profit0.00
Operating Income-18.14M
Pretax Income-11.51M
Net Income-11.51M
EBITDA-11.30M
Earnings Per Share (EPS)-56.94
Cash Flow
In the last 12 months, operating cash flow was -6.55M and capital expenditures -6.28K, giving a free cash flow of -6.56M billion.
Operating Cash Flow-6.55M
Free Cash Flow-6.56M
Free Cash Flow per Share-8.88
Dividends & Yields
ENDRA Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.86
52-Week Price Change-98.35%
50-Day Moving Average3.89
200-Day Moving Average5.58
Relative Strength Index (RSI)42.45
Average Volume (3m)73.71K
Important Dates
ENDRA Life Sciences upcoming earnings date is Aug 18, 2025, TBA Not Confirmed.
Last Earnings DateMay 15, 2025
Next Earnings DateAug 18, 2025
Ex-Dividend Date―
Financial Position
ENDRA Life Sciences as a current ratio of 5.67, with Debt / Equity ratio of 7.59%
Current Ratio5.67
Quick Ratio5.67
Debt to Market Cap0.46
Net Debt to EBITDA0.23
Interest Coverage Ratio0.00
Taxes
In the past 12 months, ENDRA Life Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
ENDRA Life Sciences EV to EBITDA ratio is 0.12, with an EV/FCF ratio of 0.19.
EV to Sales0.00
EV to EBITDA0.12
EV to Free Cash Flow0.19
EV to Operating Cash Flow0.19
Balance Sheet
ENDRA Life Sciences has $2.06M in cash and marketable securities with $587.30K in debt, giving a net cash position of -$1.48M billion.
Cash & Marketable Securities$2.06M
Total Debt$587.30K
Net Cash-$1.48M
Net Cash Per Share-$2.00
Tangible Book Value Per Share$12.67
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for ENDRA Life Sciences is $46.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$46.00
Price Target Upside1342.01% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast71.89%